Unilabs SubHolding AB (publ) (the “Issuer”) today announced that it has priced its offering of €250,000,000 aggregate principal amount of 5.75% senior notes due 2025 (the “Notes”). The offering is expected to close on May 5, 2017.
European medical diagnostics leader Unilabs reports a strong start into to 2017, delivering the 11th consecutive quarter of EBITDA growth. Commenting on the results, Jos Lamers, Chief Executive Officer stated, “What makes this quarter particularly noteworthy is that we have generated strong growth across both our Lab and Imaging segments as well as our various regions. This is also our 11th consecutive quarter delivering a sustainable organic EBITDA growth.”
Geneva, Switzerland, based European medical diagnostics leader Unilabs has completed the acquisition of Alpha Medical group from private equity firm Mid Europa Partners for an undisclosed amount. This follows the announcement of the agreement on February 9th, 2017.
Geneva based Unilabs today announced that it has reached an agreement to acquire Alpha Medical, a leading medical diagnostics company serving customers in Slovakia and the Czech Republic, from private equity firm Mid Europa Partners for an undisclosed amount.
Unilabs and funds advised by Apax Partners LLP announce that the purchase by Apax IX of Unilabs shares from Nordic Capital Fund VI and Apax France VII is complete and has now closed following clearance by the European Commission under the EU Merger Regulation.